General Genomics, with a valuation cap of $50 million, is raising crowdfunding on Wefunder. The company has developed a health platform, Curo46, to understand the complexities of individual health. The platform uses AI and other algorithms to collect medical data, medical history, genetic markers, and other information. The data is then used for risk evaluations, medical diagnosis, and treatments. AJ Rosenthal founded General Genomics in April 2020. The proceeds of the current crowdfunding round, with a minimum goal of $50,000 and a maximum goal of $1,070,000, will be used for marketing and customer acquisition, hiring employees, paying rent, electricity, and other expenses, and research and development. General Genomics’ technology will revolutionize the understanding of individual health risks, especially during the ongoing coronavirus pandemic.